Dupont Capital Management Corp Cyma Bay Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$3.23 - $4.6 $182,982 - $260,594	-56,651 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$3.47 - $4.42 $27,784 - $35,390	-8,007 Reduced 12.38%	56,651 $207,000
Q2 2021 Jul 30, 2021	BUY	$3.94 - $4.92 $99,366 - $124,082	25,220 Added 63.95%	64,658 $282,000
Q1 2021 Apr 29, 2021	SELL	$4.23 - $6.55 $34,216 - $52,982	-8,089 Reduced 17.02%	39,438 $179,000
Q4 2020 Jan 28, 2021	SELL	$5.73 - $9.03 $20,324 - $32,029	-3,547 Reduced 6.94%	47,527 $273,000
Q3 2020 Oct 29, 2020	BUY	$3.32 - $7.24 $169,565 - $369,775	51,074 New	51,074 $370,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.